Posted by Michael Wonder on 13 Jul 2025
Delgocitinib for the treatment of patients with moderate to severe chronic hand eczema
8 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use of delgocitinib in the NHS in England.
For the time being, delgocitinib should not be used for the treatment of adults with moderate to severe chronic hand eczema when topical corticosteroids have not worked or are not suitable.
